Novel antipsychotics specificity profile: A clinically oriented review of lurasidone, brexpiprazole, cariprazine and lumateperone

dc.contributor.author	Corponi, Filippo
dc.contributor.author	Fabbri, Chiara
dc.contributor.author	Bitter, István
dc.contributor.author	Montgomery, Stuart
dc.contributor.author	Vieta, Eduard
dc.contributor.author	Kasper, Siegfried
dc.contributor.author	Pallanti, Stefano
dc.contributor.author	Serretti, Alessandro
dc.date.accessioned	2020-03-31T11:38:01Z
dc.date.available	2020-03-31T11:38:01Z
dc.date.issued	2019
dc.identifier	85067880374
dc.identifier.citation	journalVolume=29;journalIssueNumber=9;journalTitle=EUROPEAN NEUROPSYCHOPHARMACOLOGY;pagerange=971-985;journalAbbreviatedTitle=EUR NEUROPSYCHOPHARM;
dc.identifier.uri	http://repo.lib.semmelweis.hu//handle/123456789/7481
dc.identifier.uri	doi:10.1016/j.euroneuro.2019.06.008
dc.format.extent	971-985
dc.relation.ispartof	urn:issn:0924-977X
dc.title	Novel antipsychotics specificity profile: A clinically oriented review of lurasidone, brexpiprazole, cariprazine and lumateperone
dc.type	Journal Article
dc.date.updated	2019-08-15T07:31:32Z
dc.language.rfc3066	en
dc.rights.holder	NULL
dc.identifier.mtmt	30765633
dc.contributor.department	SE/AOK/K/Pszichiátriai és Pszichoterápiás Klinika
dc.contributor.institution	Semmelweis Egyetem